NeoStem to Present at Multiple May and June Conferences NEW

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
NeoStem to Present at Multiple May and June Conferences

NEW YORK, May 4, 2015 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq: NBS ), a biopharmaceutical company developing novel cell-based individualized medicine therapies, announced today that the Company's management and experts will present at multiple conferences in May and early June.

Research Seminar Series, Li Ka Shing Knowledge Institute (LKSKI)

World Stem Cells and Regenerative Medicine Congress

  • Date and Time: Wednesday, May 20, 2015, 3:30 PM GMT
  • Venue: Business Design Centre, London
  • Website: http://www.terrapinn.com/conference/stem-cells/
  • Presenter: Dr. Robert Preti, President of PCT, Chief Scientific Officer of NeoStem
  • Topic: Accelerating Time To Market: Development and manufacturing considerations for cell therapy product commercialization

2015 Marcum MicroCap Conference

12th International Symposium on Stem Cell Therapy & Cardiovascular Innovations

  • Date and Time: Thursday, May 28, 2015, 11:18 AM CET
  • Venue: Aula Magna. Pabellón Docente. Hospital Universitario Gregorio Marañón, Madrid, Spain
  • Website: http://www.cardiovascularcelltherapy.com/
  • Presenter: Dr. Douglas Losordo, Chief Medical Officer
  • Topic: Cell based therapies to prevent and cure heart failure.  More than an adventure?

International Society for Cell Therapy 2015 Annual Meeting

  • Date and Time: Friday, May 29, 2015, 12:45 PM PT
  • Venue: Caesars Palace, Las Vegas, Nevada
  • Website: http://www.celltherapysociety.org/
  • Workshop Participant: Dr. Jacob Ceccarelli, Biotechnology Engineer, PCT
  • Topic: Corporate Tutorial – Fresenius Kabi

2015 ASCO Annual Meeting

  • Date and Time: Monday, June 1, 2015, 1:15 – 4:15 PM CT
  • Venue: McCormick Place, Chicago, Illinois
  • Website: http://am.asco.org/
  • Presenter: Dr. Robert O. Dillman, Vice President, Oncology
  • Poster: Phase III multicenter trial of eltrapuldencel-T: Autologous dendritic cells loaded with irradiated autologous tumor cells (DC-TC) in granulocyte-macrophage colony stimulating factor (GM-CSF) in patients with metastatic melanoma (Intus trial)

About NeoStem, Inc.

NeoStem is a biopharmaceutical company pursuing the preservation and enhancement of human health globally through the development of novel cell-based individualized medicine therapeutics that prevent, treat or cure disease. The Company is developing therapies based on three platform technologies (immuno-oncology, ischemic repair and immunomodulation) with a lead, late-stage clinical program for each. The combination of a rich therapeutics pipeline and an externally recognized in-house center for cell therapy process development and manufacturing has created an organization with unique capabilities for accelerated and efficient product development. www.neostem.com

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy, the Company's ability to develop and grow its business, the successful development of cellular therapies with respect to the Company's research and development and clinical evaluation efforts in connection with the Company's Immuno-oncology Program, Ischemic Repair Program, Immune Modulation Program and other cell therapies, the future of the regenerative medicine industry and the role of stem cells and cellular therapy in that industry, and the performance and planned expansion of the Company's wholly-owned subsidiary and its center of excellence for cell therapy process development, engineering and manufacturing, PCT, as well as its efforts to expand its capabilities into the cell therapy tools market. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on March 2, 2015, and in the Company's other periodic filings with the SEC. The Company's further development is highly dependent on future medical and research developments and market acceptance, which is outside of its control.

NeoStem, Inc. Eric Powers Manager of Communications and Marketing Phone: +1-212-584-4173 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

China, Europe, Africa Team Up for Green Energy Push

Updated Category News Views 128

The Need for Unity in a Warming World Some folks out there might be scratching their heads, wondering what sparks are flying between China, Europe, and Africa this time. Well, during the 2026 China-Europe-Africa Green Energy Development Forum held in sunny Zhejiang, the theme was loud and clear: We've got to deepen green partnerships to build a zero-carbon future. They're...

Continue Reading
Delta Marks 19 Years at COP With Bold New Initiatives

Updated Category News Views 44

Delta's Commitment to Global Sustainability Delta's name pops up yet again at the United Nations Climate Change Conference (COP31) in Antalya, Turkey, marking the company's 19th consecutive year of participation. They're mounting efforts to hit that "35×35" target, aiming for 35% electrification by 2035. This isn't just fluff and rhetoric—it’s Delta taking the lead...

Continue Reading
CHARMANT Eyewear Fuses Fashion and Functionality

Updated Category News Views 8

Eyewear ain’t just about seeing clearly anymore—it’s fashion with a capital ‘F’. The CHARMANT Japanese Made brand decided to foist this idea upon the world, putting their money where your eyeballs are, by injecting a dose of trendy glam into what they already do so well: comfort. Fusion of Style and Comfort Catch this: CHARMANT hit the global stage back in June...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 322

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Valmet Expands Board Maker Deal in Asia With New Line

Updated Category News Views 199

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 20

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 172

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
Higer Buses Debut in UK: Expansion on Full Throttle

Updated Category News Views 66

Shifting Gears in the UK: Higer Enters the Fray You don't just waltz into the UK's bus and coach market without making some serious noise. Well, Higer is doing just that at Euro Bus Expo 2026. Birmingham's NEC turned into a stage for their showdown, where they unveiled three models: Azure 9, V12, and V10. The star of the show, the Azure 9, is tailored just for the Brits,...

Continue Reading
Segway Powersports Ventures into Baja 1000: Ambitions Run High

Updated Category News Views 149

They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...

Continue Reading
Leatt Gears Up for Q3 Results Conference Call

Updated Category News Views 27

A good heads-up, folks, isn't just about keeping helmets snug—it’s about knowing when to cash in, especially when Leatt Corporation's got their Q3 results ready to drop. November 12 is the big day, so circle that on your calendars. They're rolling out the numbers before the market even gets its coffee, possibly nudging the ticker, OTCQB:LEAT, in a ripple you’ll want...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Developments from Compass Therapeutics at Upcoming Meeting

Updated Category News Views 79

Upcoming Poster Presentation Announcement Compass Therapeutics, Inc. (NASDAQ: CMPX), a pioneering clinical-stage biopharmaceutical company specializing in oncology, has announced an exciting opportunity to showcase its research at the upcoming 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting. This event is scheduled to take place from November 8–10, 2024,...

Continue Reading
Good Times Restaurants Posts Positive Growth in Q1 2025

Updated Category News Views 186

Good Times Restaurants Reports Strong Financial Performance Good Times Restaurants Inc. (NASDAQ: GTIM), the well-known operator of popular dining brands like Bad Daddy's Burger Bar and Good Times Burgers & Frozen Custard, has released its financial results for the first quarter of the fiscal year. The company has shown robust growth, signaling a positive trend in its...

Continue Reading
Alaska Air Group Reveals Financial Outlook and Updates

Updated Category News Views 124

Alaska Air Group Provides Financial Update Today, Alaska Air Group, Inc. (NYSE: ALK), a leading American airline, revealed important information regarding its financial outlook through an official filing with the Securities and Exchange Commission (SEC). This update outlines the company’s present financial conditions and operations, providing key insights valuable to...

Continue Reading
Transforming Tool Tracking Software for Unmatched Efficiency

Updated Category News Views 184

Expanding Tool Tracking Software Market Dynamics The global tool tracking software industry is on an impressive trajectory, experiencing substantial growth. Currently valued at approximately US$ 39.02 billion, the market is expected to escalate to US$ 124.90 billion by 2033. This marks a notable compound annual growth rate (CAGR) of 13.8%, highlighting the increasing...

Continue Reading
Major Developments in Class Actions for Driven Brands and More

Updated Category News Views 200

Investigating Shareholder Claims for Driven Brands Holdings, Inc. As a long-term shareholder of Driven Brands Holdings, Inc. (NASDAQ: DRVN), you may be interested in the ongoing investigation by the Grabar Law Office. This investigation seeks answers on whether certain company officers have fulfilled their fiduciary responsibilities. If you have held your shares...

Continue Reading